ArticleJHEP reports : innovation in hepatology2024

AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma.

N P Syamprasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.